Vanguard Group Inc Diffusion Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$3.34 - $4.7 $21,813 - $30,695
-6,531 Reduced 8.98%
66,232 $221,000
Q4 2022

Feb 10, 2023
BUY
$4.64 - $6.52 $194 - $273
42 Added 0.06%
72,763 $368,000
Q3 2022

Nov 14, 2022
SELL
$5.35 - $8.38 $38,782 - $60,746
-7,249 Reduced 9.06%
72,721 $389,000
Q2 2022

Aug 12, 2022
BUY
$5.66 - $14.0 $452,630 - $1.12 Million
79,970 New
79,970 $534,000

Others Institutions Holding DFFN

# of Institutions
2
Shares Held
49
Call Options Held
0
Put Options Held
0
View Full List

About Diffusion Pharmaceuticals Inc.

DFFN Quotes by TradingView
  • Ticker DFFN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,039,120
  • Market Cap $18.9M
  • Description
  • Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 a...
More about DFFN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email